Droplet digital PCR is helping to advance complex products—from gene therapies to customized cancer drugs

With an increasing need for large data analysis and validation, this Insight article takes an in-depth look at some of the recent advances in automation technologies affecting the flow cytometry field.

How can the biomarkers industry best implement multi-parameter flow cytometry in clinical drug development? Vilma Decman of GlaxoSmithKline takes us through the advantages of using spectral flow cytometry, the importance of viability dyes, and high-parameter panel design.

What are the key market trends and challenges facing the Biomarker industry today? We sat down with an advisory group of leading pharmaceutical and biotechnology experts to discuss our latest Biomarkers Week Conference and the exciting insights it disclosed.

RNAscope™ technology from Advanced Cell Diagnostics (ACD), a Bio-Techne brand, enables RNA target expression analysis within intact cells and tissue with high sensitivity and specificity in both chromogenic and fluorescence assays.

Presented by Steven Anderson, Senior Vice President & Chief Scientific Officer, Labcorp Drug Development | Akanksha Gupta, Head of Immunology, Biomarker Solution Center, Labcorp Drug Development | Kelly Y Chun, Vice President, Research & Development, Labcorp Diagnostics

Presented by Marianne Scheel Fjording, Scientific Officer at BioAgilytix

Webinar presented by Jeff Buckthal, Senior Business Development Manager at Owlstone Medical & Dr. Robert Mohney, Head of Clinical and Translational Science at Owlstone Medical

Presentations by John Chappell, Application & Service Director EMEA and Asia Pacific, Gyros Protein Technologies | Carina Carter, Senior Scientist, EMD Serono, Inc. | Claire Seal, PhD, Principal Scientist, F-Star Biotechnology